Assessment of the relationship between methylenetetrahydrofolate reductase polymorphism and acute lymphoblastic leukemia: Evidence from an updated meta-analysis
Restricted accessResearch articleFirst published online October, 2020
Assessment of the relationship between methylenetetrahydrofolate reductase polymorphism and acute lymphoblastic leukemia: Evidence from an updated meta-analysis
The methylenetetrahydrofolate reductase gene C677T polymorphism is closely related to the acute lymphoblastic leukemia. Several case–control studies have investigated this association; however, no conclusions could be drawn. A comprehensive updated meta-analysis is established to explain these contradictions and clarify the overall impact of this variant on the susceptibility to acute lymphoblastic leukemia.
Methods
Electronic searches were conducted to select published studies prior to June 2018. Pooled odds ratios and stratification analysis were performed under different genetic comparison models, age, and ethnicity.
Results
Totally, 66 case–control studies including 9619 acute lymphoblastic leukemia cases and 17,396 controls were selected. Our analyses showed that methylenetetrahydrofolate reductase C677T polymorphism was protective mainly in Asian and European countries, under all genetic models and regardless of age, but leukemogenic in mixed population.
Conclusion
Thus, C677T polymorphism may be a promising acute lymphoblastic leukemia biomarker, but they should be interpreted with caution considering other factors such as folic acid intake, gene–gene and gene–environment interactions.
SkibolaCFSmithMTKaneE, et al.
Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults.Proc Natl Acad Sci USA1999;
96: 12810–12815.
2.
ChenBAJiangNJiMJ, et al. A new method for 5, 10-methylenetetrahydrofolate reductase single nucleotide polymorphisms genotyping used to study susceptibility of hematological malignancy. Zhongguo Shi Yan Xue Ye Xue Za Zhi2006;
14: 1069–1073.
3.
Barbosa CG, Souza CL, Moura Neto JPd, et al. Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil. Genetics and Molecular Biology 2008; 31: 29–32.
4.
GuentherBDSheppardCATranP.The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia.Nat Struct Biol1999;
6: 359–365.
5.
WiemelsJLSmithRNTaylorGM, et al.
Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia.Proc Natl Acad Sci USA2001;
98: 4004–4009.
6.
Miranda-VilelaAL.Role of methylenetetrahydrofolate reductase (Mthfr), glutathione S-transferases (Gsts M1 and T1) and haptoglobin (Hp) gene polymorphisms in susceptibility to chronic myeloid leukemia (Cml). J Hematol Thromboembolic Dis2013;
1: 103–118.
7.
Martorell-MaruganJToro-DominguezDAlarcon-RiquelmeME, et al.
MetaGenyo: a web tool for meta-analysis of genetic association studies.BMC Bioinformatics2017;
18: 563.
8.
EggerMDaveySGSchneiderM, et al.
Bias in meta-analysis detected by a simple, graphical test.BMJ1997;
315: 629–634.
9.
AzharMRRahimiZVaisi-RayganiA, et al.
Lack of association between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in the Kurdish population from Western Iran.Genet Test Mol Biomarkers2012;
16: 198–202.
10.
AmigouARudantJOrsiL, et al.
Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE).Cancer Causes Control2012;
23: 1265–1277.
11.
KaluznaEMStraussESwiatek-KoscielnaB, et al.
The methylenetetrahydrofolate reductase 677T-1298C haplotype is a risk factor for acute lymphoblastic leukemia in children.Medicine2017;
96: e9290.
12.
ZouRHeXWuY, et al.
TS gene polymorphisms correlate with susceptibility to acute lymphocytic leukemia in children.Med Sci Monit2017;
23: 3095–3104.
13.
XiaXDuanYCuiJ, et al.
Association of methylenetetrahydrofolate reductase gene-gene interaction and haplotype with susceptibility to acute lymphoblastic leukemia in Chinese children.Leuk Lymphoma2017;
58: 1887–1892.
14.
BahariGHashemiMNaderiMTaheriM. Association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in an Iranian population. Int J Hematol Oncol Stem Cell Res2016;
10: 130–137.
15.
Gutierrez-AlvarezOLares-AsseffIGalaviz-HernandezC, et al.
Involvement of MTHFR and TPMT genes in susceptibility to childhood acute lymphoblastic leukemia (ALL) in Mexicans.Drug Metab Pers Ther2016;
31: 41–46.
16.
LiuPZhangMXieX, et al.
Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults.Tumour Biol2016;
37: 3265–3275.
17.
MosaadYMAbousamraNKElasheryR, et al.
Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children.Leuk Lymphoma2015;
56: 2699–2705.
18.
GoricarKErculjNFaganel KotnikB, et al.
The association of folate pathway and DNA repair polymorphisms with susceptibility to childhood acute lymphoblastic leukemia.Gene2015;
562: 203–209.
19.
SazawalSChaubeyRKaurP, et al.
MTHFR gene polymorphisms and the risk of acute lymphoblastic leukemia in adults and children: a case control study in India.Indian J Hematol Blood Transfus2014;
30: 219–225.
20.
LiXLiaoQZhangS, et al.
Association of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with the susceptibility of childhood acute lymphoblastic leukaemia (ALL) in Chinese population.Eur J Med Res2014;
19: 5.
21.
BellampalliRPhaniNMBhatKG, et al.
Significance of 5,10-methylenetetrahydrofolate reductase gene variants in acute lymphoblastic leukemia in Indian population: an experimental, computational and meta-analysis.Leuk Lymphoma2015;
56: 1450–1459.
22.
KarathanasisNVStiakakiEGoulielmosG, et al.
The effect of RFC G80A polymorphism in Cretan children with acute lymphoblastic leukemia and its interaction with MTHFR C677T and A1298C polymorphisms.Int J Lab Hematol2014;
36: 425–430.
23.
Roy MoulikNParveenFKumarA, et al.
MTHFR gene polymorphism in acute lymphoblastic leukemia among North Indian children: a case-control study and meta-analysis updated from 2011.J Hum Genet2014;
59: 397–404.
24.
KreileMRotsDPiekuseL, et al.
Lack of association between polymorphisms in genes MTHFR and MDR1 with risk of childhood acute lymphoblastic leukemia.Asian Pac J Cancer Prev2014;
15: 9707–9711.
25.
ZhengMMYueLJChenXW, et al.
[Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia]. Zhongguo Dang Dai Er Ke Za Zhi2013;
15: 201–206.
26.
SilvaRMFontesACSilvaKA, et al.
Polymorphisms involved in folate metabolism pathways and the risk of the development of childhood acute leukemia.Genet Test Mol Biomarkers2013;
17: 147–152.
27.
HussainSRNaqviHRazaST, et al.
Methylenetetrahydrofolate reductase C677T genetic polymorphisms and risk of leukaemia among the North Indian population.Cancer Epidemiol2012;
36: e227–e231.
28.
NikbakhtMMalekZadehKKumar JhaA, et al.
Polymorphisms of MTHFR and MTR genes are not related to susceptibility to childhood ALL in North India.Exp Oncol2012;
34: 43–48.
29.
LiXLYuFZhangY, et al.
[Study on the association between 5,10-methylenetrahydrofolate reductase C677T polymorphism and acute lymphoblastic leukemia risk: a Meta-analysis].Zhonghua Liu Xing Bing Xue Za Zhi2011;
32: 1030–1036.
30.
ChanJYUgrasenaDGLumDW, et al.
Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children.Hematol Oncol2011;
29: 116–123.
31.
te WinkelMLde Muinck Keizer-SchramaSMde JongeR, et al.
Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study.Bone2011;
48: 571–577.
32.
YangLHuXXuL.Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.Tumour Biol2012;
33: 1445–1454.
33.
TongNFangYLiJ, et al.
Methylenetetrahydrofolate reductase polymorphisms, serum methylenetetrahydrofolate reductase levels, and risk of childhood acute lymphoblastic leukemia in a Chinese population.Cancer Sci2010;
101: 782–786.
34.
SoodSDasRTrehanA, et al.
Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians.Leuk Lymphoma2010;
51: 928–932.
35.
DamnjanovicTMilicevicRNovkovicT, et al.
Association between the methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia in Serbian children.J Pediatr Hematol Oncol2010;
32: e148–e150.
36.
LightfootTJJohnstonWTPainterD, et al.
Genetic variation in the folate metabolic pathway and risk of childhood leukemia.Blood2010;
115: 3923–3929.
37.
YeohAELuYChanJY, et al.
Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group.Leuk Res2010;
34: 276–283.
38.
KantarMKosovaBCetingulN, et al.
Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.Leuk Lymphoma2009;
50: 912–917.
39.
de JongeRTissingWJHooijbergJH, et al.
Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia.Blood2009;
113: 2284–2289.
40.
KimHNKimYKLeeIK, et al.
Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies.Leuk Res2009;
33: 82–87.
41.
PietrzykJJBik-MultanowskiMBalwierzW, et al.
Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene.Pediatr Blood Cancer2009;
52: 364–368.
42.
AlcasabasPRavindranathYGoyetteG, et al.
5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children.Pediatr Blood Cancer2008;
51: 178–182.
43.
GiovannettiEUgrasenaDGSupriyadiE, et al.
Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.Leuk Res2008;
32: 19–24.
44.
KamelAMMoussaHSEbidGT, et al.
Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia. J Egypt Natl Canc Inst2007;
19: 96–105.
45.
OhDKimNKJangMJ, et al.
Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia. Anticancer Res2007;
27: 3419–3424.
46.
PetraBGJanezJVitaD.Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children.Leuk Lymphoma2007;
48: 786–792.
47.
ReddyHJamilK.Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population.Leuk Lymphoma2006;
47: 1333–1339.
48.
KimNKChongSYJangMJ, et al.
Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia. Anticancer Res2006;
26: 2879–2881.
49.
HurMParkJYChoHC, et al.
Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population.Clin Lab Haematol2006;
28: 154–159.
50.
ChatzidakisKGoulasAAthanassiadou-PiperopoulouF, et al.
Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in Greek patients.Pediatr Blood Cancer2006;
47: 147–151.
51.
ZanrossoCWHatagimaAEmerencianoM, et al.
The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population.Leuk Res2006;
30: 477–481.
52.
TimuragaogluADizlekSUysalgilN, et al.
Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.Ann Hematol2006;
85: 863–868.
53.
SchnakenbergEMehlesACarioG, et al.
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population.BMC Med Genet2005;
6: 23.
54.
OliveiraEAlvesSQuentalS, et al.
The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal.J Pediatr Hematol Oncol2005;
27: 425–429.
55.
ThirumaranRKGastAFlohrT, et al.
MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.Blood2005;
106: 2590–2591.
56.
KrajinovicMLamotheSLabudaD, et al.
Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.Blood2004;
103: 252–257.
57.
GemmatiDOngaroAScapoliGL, et al.
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin’s lymphoma in adults. Cancer Epidemiol Biomarkers Prev2004;
13: 787–794.
58.
ChiusoloPReddicontoGCiminoG, et al.
Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian population.Haematologica2004;
89: 139–144.
59.
BaltaGYuksekNOzyurekE, et al.
Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.Am J Hematol2003;
73: 154–160.
60.
DeligezerUAkisikEDalayN.Genotyping of the MTHFR gene polymorphism, C677T in patients with leukemia by melting curve analysis.Mol Diagn2003;
7: 181–185.
61.
FrancoRFSimoesBPToneLG, et al.
The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia.Br J Haematol2001;
115: 616–618.
62.
PeiJSHsuCMTsaiCW, et al.
The association of methylenetetrahydrofolate reductase genotypes with the risk of childhood leukemia in Taiwan.PLoS One2015;
10: e0119776.
63.
ZhengMMYueLJZhangHH, et al.
[Association of single nucleotide polymorphism of methylenetetrahydrofolate reductase gene with susceptibility to acute leukemia]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi2013;
30: 451–455.
64.
LvHWangWDuZZ, et al.
Relationship between genetic polymorphism of methylenetetrahydrofolate reductase and the risk of childhood acute lymphocytic leukemia. J Clin Pediatr2011;
29: 414–417.
65.
FengYCWuJR.Relationship between genetic polymorphism of methylenetetrahydrofolate reductase and the risk of childhood acute lymphocytic leukemia. J Leukemia Lymphoma2012;
21: 736–738.
66.
YuHJinRMBaiY, et al.
The relationship between the methylenetetrahydrofolate reductase C677T gene polymorphism and acute lymphocytic leukemia in children. J Clin Hematol2006;
19: 205–206.
67.
JiangHGuLJXueHL, et al.
Methylenetetrahydrofolate reductase gene polymorphism in childhood acute lymphocytic leukaemia. Chin J Hematol2004;
25: 439–440.
68.
ZhangJ.A study on the serum folate level and methylenetetrahydrofolate reductase genetic polymorphisms in adult acute lymphocytic leukemia.
Shijiazhuang:
Hebei Medical University, 2007.
69.
ZhangBZhangWYanL, et al.
The association between MTHFR gene C677T polymorphism and ALL risk based on a meta-analysis involving 17,469 subjects.Clin Chim Acta2017;
466: 85–92.
70.
XiaoYDengTRSuCL, et al.
Methylenetetrahydrofolate reductase polymorphisms and susceptibility to acute lymphoblastic leukemia in a Chinese population: a meta-analysis.Oncol Res Treat2014;
37: 576–582.
71.
LinSLiuQZengX.The association between methylenetetrahydrofolate reductase C677 > T polymorphisms and risk of pediatric acute lymphoblastic leukemia in Asia.J Cancer Res Ther2014;
10: C210–C214.
72.
LienSAYoungLGauBS, et al.
Meta-prediction of MTHFR gene polymorphism-mutations, air pollution, and risks of leukemia among world populations.Oncotarget2017;
8: 4387–4398.
